Lee Chan Henry (CIK 1980648) reported 69 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-18). Recent activity: Sell ONC (590 shares), Sell ONC (711 shares), Sell ONC (160 shares), Buy ONC (101 shares), Buy ONC (133 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 590 | $156,925 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 711 | $192,138 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 160 | $43,401 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 101 | $19,641 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 133 | $28,372 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 98 | $15,585 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 332 | $103,159 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 101 | $19,641 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 133 | $28,372 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 98 | $15,585 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 332 | $103,448 |
| 2026-03-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 133 | $28,372 |
| 2026-03-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 110 | $21,392 |
| 2026-03-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 98 | $15,585 |
| 2026-03-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 341 | $102,300 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 65,390 | $0 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 29,874 | $0 |
| 2026-02-06 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 502 | $97,624 |
| 2026-02-06 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 662 | $141,218 |
| 2026-02-06 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 496 | $78,879 |
| 2026-02-06 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 664 | $231,597 |
| 2026-02-06 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 996 | $348,600 |
| 2026-01-09 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 196 | $31,170 |
| 2026-01-09 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 202 | $39,283 |
| 2026-01-09 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 266 | $56,743 |
Source: SEC Form 4 filings · as of 2026-06-18